Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05619588 · ClinicalTrials.gov registry record
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
A clinical trial of Ankle Rheumatoid Arthritis and Arthritis of Ankle, sponsored by Exactech.
- Recruiting
- Registry status
- 370
- Enrollment target
- 2
- Study locations
NCT05619588: Recruiting study of Ankle Rheumatoid Arthritis and Arthritis of Ankle, sponsored by Exactech.
NCT05619588 is a study of Ankle Rheumatoid Arthritis and Arthritis of Ankle that is actively recruiting participants, run by Exactech. The registered enrollment target is 370 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05619588, a study of Ankle Rheumatoid Arthritis and Arthritis of Ankle, is actively recruiting participants, sponsored by Exactech.
- RECRUITING
- Registry status
- 370 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objectives of this study are to evaluate the performance and safety of the Vantage Total Ankle System. This study will follow subjects for a period of up to 10 years post-surgery.
Primary Outcome
American Orthopedic Foot and Ankle Society Score (AOFAS) - Questionaire on pain (40 points), function (45 points) , and alignment (15 points) - 100 points score where 100 indicates a healthy midfoot
Conditions Studied
Study Locations (2)
Florida
- Mayo Clinic - Jacksonville
North Carolina
- Duke Department of Orthopaedic Surgery - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2031-09-30 |
What NCT05619588 shows while recruiting
NCT05619588 is an observational study that tracks outcomes without assigning an intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Ankle Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT05619588 reports a single indexed study location in Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05619588 about?
NCT05619588 is a clinical study titled "Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only". The objectives of this study are to evaluate the performance and safety of the Vantage Total Ankle System. This study will follow subjects for a period of up to 10 years post-surgery.
What is the current status of trial NCT05619588?
This trial is currently recruiting. The enrollment target is 370 participants. The study started on 2017-04-04. Estimated completion is 2031-09-30.
What conditions does trial NCT05619588 study?
This clinical trial studies the following conditions: Ankle Rheumatoid Arthritis, Arthritis of Ankle, Failure, Prosthesis.
Who is sponsoring clinical trial NCT05619588?
This trial is sponsored by Exactech, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05619588 being conducted?
This trial has 2 study locations across Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI